Immunocore Holdings Plc (IMCR)
32.93
+0.25
(+0.76%)
USD |
NASDAQ |
Feb 23, 16:00
32.91
-0.02
(-0.06%)
After-Hours: 19:59
Immunocore Holdings Total Assets (Quarterly) : 1.102B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Silence Therapeutics Plc | 146.79M |
| Adaptimmune Therapeutics Plc | 130.63M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 43.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 705.94M |
| Shareholders Equity (Quarterly) | 396.56M |
| Debt to Equity Ratio | 1.099 |
| Current Ratio | 6.004 |
| Net Debt Paydown Yield | 0.40% |